サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1411583

クロストリジウム診断薬市場：診断テスト別、エンドユーザー別-2024-2030年の世界予測

Clostridium Diagnostics Market by Diagnostic Test (Blood Test, Colonoscopy/Sigmoidoscopy, Enzyme Immunoassays), End User (Diagnostic Centers, Hospitals, Specialty Clinics) - Global Forecast 2024-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 189 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
クロストリジウム診断薬市場：診断テスト別、エンドユーザー別-2024-2030年の世界予測
出版日: 2024年01月16日
発行: 360iResearch
ページ情報: 英文 189 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

クロストリジウム診断薬市場規模は2023年に14億3,000万米ドルと推計され、2024年には15億1,000万米ドルに達し、CAGR 6.33%で2030年には22億米ドルに達すると予測されます。

クロストリジウム診断薬の世界市場

主な市場の統計
基準年[2023］ 14億3,000万米ドル
予測年[2024］ 15億1,000万米ドル
予測年 [2030] 22億米ドル
CAGR（%） 6.33%
クロストリジウム診断薬 Market-IMG1

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスはクロストリジウム診断薬市場を評価する上で極めて重要です。事業戦略と製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、クロストリジウム診断薬市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1-市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1-クロストリジウム診断薬市場の市場規模および予測は？

2-クロストリジウム診断薬市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3-クロストリジウム診断薬市場における技術動向と規制の枠組みは？

4-クロストリジウム診断薬市場における主要ベンダーの市場シェアは？

5-クロストリジウム診断薬市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • クロストリジウム関連疾患の高い有病率
      • 世界的に高齢者人口が増加
    • 抑制要因
      • 診断テストによる偽陽性または偽陰性結果の潜在的なリスク
    • 機会
      • 診断装置におけるAIの統合と自動化
      • ポータブルPOCT製品の採用
    • 課題
      • 発展途上地域における診断センターの認知度と利用可能性が限られている
  • 市場セグメンテーション分析
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 クロストリジウム診断薬市場診断テスト別

  • 血液検査
  • 結腸内視鏡検査/S状結腸鏡検査
  • 酵素免疫測定法
  • 核酸増幅検査（NAAT）
  • 反応（RT-PCR）
  • リアルタイムポリメラーゼチェーン
  • 便検査

第7章 クロストリジウム診断薬市場：エンドユーザー別

  • 診断センター
  • 病院
  • 専門クリニック

第8章 南北アメリカのクロストリジウム診断薬市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第9章 アジア太平洋地域のクロストリジウム診断薬市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第10章 欧州・中東・アフリカのクロストリジウム診断薬市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第11章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ主要企業別の分析

第12章 競争力のあるポートフォリオ

  • 主要な企業プロファイル
    • Abbott Laboratories
    • altona Diagnostics GmbH
    • Beckman Coulter, Inc.
    • Becton, Dickinson & Company
    • bioMerieux SA
    • Cepheid
    • DiaSorin SpA
    • F. Hoffmann-La Roche AG
    • Ferring BV
    • Fujirebio Holdings Inc.
    • Hologic, Inc.
    • Luminex Corporation
    • Merck & Co., Inc.
    • Meridian Bioscience, Inc.
    • Molbio Diagnostics Pvt. Ltd.
    • Olympus Corporation
    • Pfizer Inc.
    • QIAGEN NV
    • Quidel Corporation
    • R-Biopharm AG
    • Summit Therapeutics, Inc.
    • Sysmex Corporation
    • Thermo Fisher Scientific, Inc.
    • Trinity Biotech Plc
    • ZeptoMetrix, LLC
  • 主要な製品ポートフォリオ

第13章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. CLOSTRIDIUM DIAGNOSTICS MARKET RESEARCH PROCESS
  • FIGURE 2. CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. CLOSTRIDIUM DIAGNOSTICS MARKET DYNAMICS
  • FIGURE 7. CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2023 VS 2030 (%)
  • FIGURE 8. CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 10. CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. AMERICAS CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 12. AMERICAS CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 14. UNITED STATES CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. ASIA-PACIFIC CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. ASIA-PACIFIC CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. CLOSTRIDIUM DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 20. CLOSTRIDIUM DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. CLOSTRIDIUM DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 6. CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY BLOOD TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY COLONOSCOPY/SIGMOIDOSCOPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY ENZYME IMMUNOASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY NUCLEIC AMPLIFICATION TESTS (NAAT), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY REACTION (RT-PCR), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY REAL-TIME POLYMERASE CHAIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY STOOL TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 14. CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 22. BRAZIL CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 23. BRAZIL CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 24. CANADA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 25. CANADA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 26. MEXICO CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 27. MEXICO CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 30. UNITED STATES CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 33. ASIA-PACIFIC CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 34. AUSTRALIA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 35. AUSTRALIA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 36. CHINA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 37. CHINA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 38. INDIA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 39. INDIA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 40. INDONESIA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 41. INDONESIA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 42. JAPAN CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 43. JAPAN CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 44. MALAYSIA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 45. MALAYSIA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 46. PHILIPPINES CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 47. PHILIPPINES CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 48. SINGAPORE CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 49. SINGAPORE CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. SOUTH KOREA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 51. SOUTH KOREA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 52. TAIWAN CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 53. TAIWAN CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 54. THAILAND CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 55. THAILAND CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 56. VIETNAM CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 57. VIETNAM CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 60. EUROPE, MIDDLE EAST & AFRICA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 61. DENMARK CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 62. DENMARK CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 63. EGYPT CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 64. EGYPT CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. FINLAND CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 66. FINLAND CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67. FRANCE CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 68. FRANCE CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 69. GERMANY CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 70. GERMANY CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. ISRAEL CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 72. ISRAEL CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 73. ITALY CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 74. ITALY CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. NETHERLANDS CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 76. NETHERLANDS CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. NIGERIA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 78. NIGERIA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 79. NORWAY CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 80. NORWAY CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 81. POLAND CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 82. POLAND CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 83. QATAR CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 84. QATAR CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 85. RUSSIA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 86. RUSSIA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. SAUDI ARABIA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 88. SAUDI ARABIA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH AFRICA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH AFRICA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 91. SPAIN CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 92. SPAIN CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 93. SWEDEN CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 94. SWEDEN CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. SWITZERLAND CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 96. SWITZERLAND CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. TURKEY CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 98. TURKEY CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED ARAB EMIRATES CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED ARAB EMIRATES CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED KINGDOM CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED KINGDOM CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 103. CLOSTRIDIUM DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 104. CLOSTRIDIUM DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 105. CLOSTRIDIUM DIAGNOSTICS MARKET LICENSE & PRICING
目次
Product Code: MRR-DD0700E81E27

[189 Pages Report] The Clostridium Diagnostics Market size was estimated at USD 1.43 billion in 2023 and expected to reach USD 1.51 billion in 2024, at a CAGR 6.33% to reach USD 2.20 billion by 2030.

Global Clostridium Diagnostics Market

KEY MARKET STATISTICS
Base Year [2023] USD 1.43 billion
Estimated Year [2024] USD 1.51 billion
Forecast Year [2030] USD 2.20 billion
CAGR (%) 6.33%
Clostridium Diagnostics Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Clostridium Diagnostics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Clostridium Diagnostics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Clostridium Diagnostics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, altona Diagnostics GmbH, Beckman Coulter, Inc., Becton, Dickinson & Company, bioMerieux SA, Cepheid, DiaSorin SpA, F. Hoffmann-La Roche AG, Ferring BV, Fujirebio Holdings Inc., Hologic, Inc., Luminex Corporation, Merck & Co., Inc., Meridian Bioscience, Inc., Molbio Diagnostics Pvt. Ltd., Olympus Corporation, Pfizer Inc., QIAGEN NV, Quidel Corporation, R-Biopharm AG, Summit Therapeutics, Inc., Sysmex Corporation, Thermo Fisher Scientific, Inc., Trinity Biotech Plc, and ZeptoMetrix, LLC.

Market Segmentation & Coverage

This research report categorizes the Clostridium Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Diagnostic Test
    • Blood Test
    • Colonoscopy/Sigmoidoscopy
    • Enzyme Immunoassays
    • Nucleic Amplification Tests (NAAT)
    • Reaction (RT-PCR)
    • Real-Time Polymerase Chain
    • Stool Test
  • End User
    • Diagnostic Centers
    • Hospitals
    • Specialty Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Clostridium Diagnostics Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Clostridium Diagnostics Market?

3. What are the technology trends and regulatory frameworks in the Clostridium Diagnostics Market?

4. What is the market share of the leading vendors in the Clostridium Diagnostics Market?

5. Which modes and strategic moves are suitable for entering the Clostridium Diagnostics Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Clostridium Diagnostics Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. High prevalence of clostridium-related disease
      • 5.1.1.2. Growing geriatric population globally
    • 5.1.2. Restraints
      • 5.1.2.1. Potential risk of false positive or false negative results through diagnostic test
    • 5.1.3. Opportunities
      • 5.1.3.1. AI integration and automation in diagnostic devices
      • 5.1.3.2. Adoption of portable POCT products
    • 5.1.4. Challenges
      • 5.1.4.1. Limited awarness and availability of diagnostic centers in developing areas
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Clostridium Diagnostics Market, by Diagnostic Test

  • 6.1. Introduction
  • 6.2. Blood Test
  • 6.3. Colonoscopy/Sigmoidoscopy
  • 6.4. Enzyme Immunoassays
  • 6.5. Nucleic Amplification Tests (NAAT)
  • 6.6. Reaction (RT-PCR)
  • 6.7. Real-Time Polymerase Chain
  • 6.8. Stool Test

7. Clostridium Diagnostics Market, by End User

  • 7.1. Introduction
  • 7.2. Diagnostic Centers
  • 7.3. Hospitals
  • 7.4. Specialty Clinics

8. Americas Clostridium Diagnostics Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Clostridium Diagnostics Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Clostridium Diagnostics Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
  • 11.2. Market Share Analysis, By Key Player
  • 11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio

  • 12.1. Key Company Profiles
    • 12.1.1. Abbott Laboratories
    • 12.1.2. altona Diagnostics GmbH
    • 12.1.3. Beckman Coulter, Inc.
    • 12.1.4. Becton, Dickinson & Company
    • 12.1.5. bioMerieux SA
    • 12.1.6. Cepheid
    • 12.1.7. DiaSorin SpA
    • 12.1.8. F. Hoffmann-La Roche AG
    • 12.1.9. Ferring BV
    • 12.1.10. Fujirebio Holdings Inc.
    • 12.1.11. Hologic, Inc.
    • 12.1.12. Luminex Corporation
    • 12.1.13. Merck & Co., Inc.
    • 12.1.14. Meridian Bioscience, Inc.
    • 12.1.15. Molbio Diagnostics Pvt. Ltd.
    • 12.1.16. Olympus Corporation
    • 12.1.17. Pfizer Inc.
    • 12.1.18. QIAGEN NV
    • 12.1.19. Quidel Corporation
    • 12.1.20. R-Biopharm AG
    • 12.1.21. Summit Therapeutics, Inc.
    • 12.1.22. Sysmex Corporation
    • 12.1.23. Thermo Fisher Scientific, Inc.
    • 12.1.24. Trinity Biotech Plc
    • 12.1.25. ZeptoMetrix, LLC
  • 12.2. Key Product Portfolio

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing